Department of Primary Health Care and General Practice and the Bioethics Centre, University of Otago, Wellington, New Zealand.
Philosophy, University of Otago, Dunedin, New Zealand.
PLoS One. 2020 Aug 5;15(8):e0235618. doi: 10.1371/journal.pone.0235618. eCollection 2020.
This is a multi-method, in-depth, three part qualitative study exploring the regulation and practice of secondary research with tissue and data in a high-income country. We explore and compare the perspectives of researchers, research ethics committees (RECs) and other relevant professionals (e.g. pathologists and clinicians). We focus on points of contention because they demonstrate misalignment between the expectations, values and assumptions of these stakeholders.
This is a multi-method study using observational research, focus groups and interviews with 42 participants (conducted 2016-2017) and analyzed using thematic analysis.
Results are arranged under the following themes: consent; balancing the social value of the research with consent requirements; and harm. Our findings demonstrate different perspectives on the review process, styles of ethical reasoning and issues of concern. First, researchers and RECs disagreed about whether the cost of re-consenting patients satisfied the criterion of impracticability for consent waivers. Second, most researchers were skeptical that secondary research with already collected tissue and data could harm patients. Researchers often pointed to the harm arising from a failure to use existing material for research. RECs were concerned about the potential for secondary research to stigmatize communities. Third, researchers adopted a more consequentialist approach to decision-making, including some willingness to trade off the benefit of the research against the cost of getting consent; whereas RECs were more deontological and typically considered research benefit only after it had been established that re-consent was impractical.
This research highlights ways in which RECs and researchers may be talking past each other, resulting in confusion and frustration. These finding provide a platform for realignment of the expectations of RECs and researchers, which could contribute to making research ethics review more effective.
本研究是一项多方法、深入的、三部分定性研究,旨在探讨在高收入国家,对组织和数据进行二次研究的监管和实践。我们探索并比较了研究人员、研究伦理委员会(RECs)和其他相关专业人员(如病理学家和临床医生)的观点。我们专注于有争议的观点,因为这些观点表明了这些利益相关者的期望、价值观和假设之间存在错位。
这是一项多方法研究,使用观察性研究、焦点小组和访谈,对 42 名参与者(2016-2017 年进行)进行了研究,并使用主题分析进行了分析。
结果分为以下主题:同意;在研究的社会价值与同意要求之间取得平衡;以及伤害。我们的研究结果表明,对审查过程、伦理推理风格和关注问题的看法存在差异。首先,研究人员和 RECs 对重新同意患者是否满足同意豁免的不切实际标准存在分歧。其次,大多数研究人员对二次研究已经收集的组织和数据可能对患者造成伤害持怀疑态度。研究人员通常指出,未能利用现有材料进行研究可能会造成伤害。RECs 担心二次研究可能会给社区带来污名化。第三,研究人员采用了更具后果主义的决策方法,包括一些愿意权衡研究的好处与获得同意的成本;而 RECs 则更注重道义论,通常在确定重新同意不切实际之后才考虑研究的好处。
本研究强调了 RECs 和研究人员可能在相互交流时存在的脱节方式,导致了困惑和挫折。这些发现为调整 RECs 和研究人员的期望提供了一个平台,这可能有助于使研究伦理审查更加有效。